vs
Side-by-side financial comparison of COLLEGIUM PHARMACEUTICAL, INC (COLL) and CareTrust REIT, Inc. (CTRE). Click either name above to swap in a different company.
COLLEGIUM PHARMACEUTICAL, INC is the larger business by last-quarter revenue ($205.4M vs $134.9M, roughly 1.5× CareTrust REIT, Inc.). CareTrust REIT, Inc. runs the higher net margin — 82.5% vs 8.3%, a 74.3% gap on every dollar of revenue. On growth, CareTrust REIT, Inc. posted the faster year-over-year revenue change (55.1% vs 12.9%). Over the past eight quarters, CareTrust REIT, Inc.'s revenue compounded faster (46.2% CAGR vs 19.1%).
Collegium Pharmaceutical, Inc. is a specialty pharmaceutical firm focused on developing and commercializing innovative, abuse-deterrent pain management therapies. Operating primarily in the U.S. market, it offers extended-release analgesics for chronic pain patients, serving providers across primary and specialty care segments.
CareTrust REIT, Inc.CTREEarnings & Financial Report
Target Healthcare REIT is a British property investment company which invests in healthcare properties and holds a large portfolio of care homes. It is structured as a real estate investment trust (REIT) and is listed on the London Stock Exchange and is a constituent of the FTSE 250 Index.
COLL vs CTRE — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $205.4M | $134.9M |
| Net Profit | $17.0M | $111.3M |
| Gross Margin | 62.5% | — |
| Operating Margin | 29.6% | — |
| Net Margin | 8.3% | 82.5% |
| Revenue YoY | 12.9% | 55.1% |
| Net Profit YoY | 35.3% | 113.5% |
| EPS (diluted) | $0.48 | $0.52 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $205.4M | $134.9M | ||
| Q3 25 | $209.4M | $132.4M | ||
| Q2 25 | $188.0M | $112.5M | ||
| Q1 25 | $177.8M | $96.6M | ||
| Q4 24 | $181.9M | $86.9M | ||
| Q3 24 | $159.3M | $77.4M | ||
| Q2 24 | $145.3M | $68.9M | ||
| Q1 24 | $144.9M | $63.1M |
| Q4 25 | $17.0M | $111.3M | ||
| Q3 25 | $31.5M | $74.9M | ||
| Q2 25 | $12.0M | $68.5M | ||
| Q1 25 | $2.4M | $65.8M | ||
| Q4 24 | $12.5M | $52.1M | ||
| Q3 24 | $9.3M | $33.4M | ||
| Q2 24 | $19.6M | $10.8M | ||
| Q1 24 | $27.7M | $28.7M |
| Q4 25 | 62.5% | — | ||
| Q3 25 | 61.7% | — | ||
| Q2 25 | 57.7% | — | ||
| Q1 25 | 54.8% | — | ||
| Q4 24 | 54.0% | — | ||
| Q3 24 | 60.8% | — | ||
| Q2 24 | 62.5% | — | ||
| Q1 24 | 63.1% | — |
| Q4 25 | 29.6% | — | ||
| Q3 25 | 29.7% | 58.1% | ||
| Q2 25 | 18.7% | 61.3% | ||
| Q1 25 | 12.2% | — | ||
| Q4 24 | 20.9% | — | ||
| Q3 24 | 21.9% | 43.0% | ||
| Q2 24 | 32.7% | 15.1% | ||
| Q1 24 | 34.1% | — |
| Q4 25 | 8.3% | 82.5% | ||
| Q3 25 | 15.0% | 56.6% | ||
| Q2 25 | 6.4% | 60.9% | ||
| Q1 25 | 1.4% | 68.1% | ||
| Q4 24 | 6.9% | 60.0% | ||
| Q3 24 | 5.9% | 43.2% | ||
| Q2 24 | 13.5% | 15.6% | ||
| Q1 24 | 19.1% | 45.6% |
| Q4 25 | $0.48 | $0.52 | ||
| Q3 25 | $0.84 | $0.35 | ||
| Q2 25 | $0.34 | $0.35 | ||
| Q1 25 | $0.07 | $0.35 | ||
| Q4 24 | $0.36 | $0.30 | ||
| Q3 24 | $0.27 | $0.21 | ||
| Q2 24 | $0.52 | $0.07 | ||
| Q1 24 | $0.71 | $0.22 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $386.7M | $198.0M |
| Total DebtLower is stronger | — | $894.2M |
| Stockholders' EquityBook value | $301.7M | $4.0B |
| Total Assets | $1.7B | $5.1B |
| Debt / EquityLower = less leverage | — | 0.22× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $386.7M | $198.0M | ||
| Q3 25 | $285.9M | $712.5M | ||
| Q2 25 | $222.2M | $306.1M | ||
| Q1 25 | $197.8M | $26.5M | ||
| Q4 24 | $162.8M | $213.8M | ||
| Q3 24 | $120.0M | $377.1M | ||
| Q2 24 | $271.6M | $495.1M | ||
| Q1 24 | $318.0M | $451.2M |
| Q4 25 | — | $894.2M | ||
| Q3 25 | — | $893.8M | ||
| Q2 25 | — | $1.2B | ||
| Q1 25 | — | $822.1M | ||
| Q4 24 | — | $396.9M | ||
| Q3 24 | — | $396.7M | ||
| Q2 24 | — | $671.1M | ||
| Q1 24 | — | $595.9M |
| Q4 25 | $301.7M | $4.0B | ||
| Q3 25 | $274.8M | $4.0B | ||
| Q2 25 | $232.2M | $3.3B | ||
| Q1 25 | $234.4M | $2.9B | ||
| Q4 24 | $228.8M | $2.9B | ||
| Q3 24 | $234.3M | $2.4B | ||
| Q2 24 | $216.6M | $1.9B | ||
| Q1 24 | $222.2M | $1.7B |
| Q4 25 | $1.7B | $5.1B | ||
| Q3 25 | $1.6B | $5.1B | ||
| Q2 25 | $1.6B | $4.7B | ||
| Q1 25 | $1.6B | $3.9B | ||
| Q4 24 | $1.7B | $3.4B | ||
| Q3 24 | $1.6B | $2.9B | ||
| Q2 24 | $1.1B | $2.7B | ||
| Q1 24 | $1.1B | $2.3B |
| Q4 25 | — | 0.22× | ||
| Q3 25 | — | 0.22× | ||
| Q2 25 | — | 0.35× | ||
| Q1 25 | — | 0.28× | ||
| Q4 24 | — | 0.14× | ||
| Q3 24 | — | 0.16× | ||
| Q2 24 | — | 0.35× | ||
| Q1 24 | — | 0.36× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $123.0M | $394.0M |
| Free Cash FlowOCF − Capex | $122.4M | — |
| FCF MarginFCF / Revenue | 59.6% | — |
| Capex IntensityCapex / Revenue | 0.3% | — |
| Cash ConversionOCF / Net Profit | 7.25× | 3.54× |
| TTM Free Cash FlowTrailing 4 quarters | $327.6M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $123.0M | $394.0M | ||
| Q3 25 | $78.4M | $100.9M | ||
| Q2 25 | $72.4M | $100.8M | ||
| Q1 25 | $55.4M | $71.4M | ||
| Q4 24 | $84.6M | $244.3M | ||
| Q3 24 | $-9.0M | $67.2M | ||
| Q2 24 | $67.4M | $53.0M | ||
| Q1 24 | $61.9M | $48.8M |
| Q4 25 | $122.4M | — | ||
| Q3 25 | $78.3M | — | ||
| Q2 25 | $72.4M | — | ||
| Q1 25 | $54.6M | — | ||
| Q4 24 | $84.1M | — | ||
| Q3 24 | $-9.2M | — | ||
| Q2 24 | $67.1M | — | ||
| Q1 24 | $61.4M | — |
| Q4 25 | 59.6% | — | ||
| Q3 25 | 37.4% | — | ||
| Q2 25 | 38.5% | — | ||
| Q1 25 | 30.7% | — | ||
| Q4 24 | 46.2% | — | ||
| Q3 24 | -5.8% | — | ||
| Q2 24 | 46.2% | — | ||
| Q1 24 | 42.3% | — |
| Q4 25 | 0.3% | — | ||
| Q3 25 | 0.1% | — | ||
| Q2 25 | 0.0% | — | ||
| Q1 25 | 0.4% | — | ||
| Q4 24 | 0.3% | — | ||
| Q3 24 | 0.2% | — | ||
| Q2 24 | 0.2% | — | ||
| Q1 24 | 0.4% | — |
| Q4 25 | 7.25× | 3.54× | ||
| Q3 25 | 2.49× | 1.35× | ||
| Q2 25 | 6.05× | 1.47× | ||
| Q1 25 | 22.92× | 1.08× | ||
| Q4 24 | 6.75× | 4.68× | ||
| Q3 24 | -0.96× | 2.01× | ||
| Q2 24 | 3.44× | 4.92× | ||
| Q1 24 | 2.23× | 1.70× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
